In functional tumors, measurement of specific hormones is appropriate [glucagon in glucagonoma, vasoactive intestinal peptide (VIP) in VIPoma, gastrin in gastrinoma, insulin in insulinoma, etc.]. The gene discussed is VIP; the disease is gastrin-producing neuroendocrine tumor.